JP2000063339A - Production of n-protective group-amino acid - Google Patents
Production of n-protective group-amino acidInfo
- Publication number
- JP2000063339A JP2000063339A JP10229609A JP22960998A JP2000063339A JP 2000063339 A JP2000063339 A JP 2000063339A JP 10229609 A JP10229609 A JP 10229609A JP 22960998 A JP22960998 A JP 22960998A JP 2000063339 A JP2000063339 A JP 2000063339A
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- carbobenzoxy
- toluene
- reaction
- phenylalanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 11
- 229940024606 amino acid Drugs 0.000 claims abstract description 32
- 150000001413 amino acids Chemical class 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 16
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 14
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 12
- 125000006239 protecting group Chemical group 0.000 claims abstract description 11
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 8
- 125000003277 amino group Chemical group 0.000 claims abstract description 7
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930182817 methionine Natural products 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 239000003960 organic solvent Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000012736 aqueous medium Substances 0.000 claims description 6
- XYUBQWNJDIAEES-QMMMGPOBSA-N (2r)-2-amino-3-phenylsulfanylpropanoic acid Chemical compound OC(=O)[C@@H](N)CSC1=CC=CC=C1 XYUBQWNJDIAEES-QMMMGPOBSA-N 0.000 claims description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 3
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 25
- 239000006227 byproduct Substances 0.000 abstract description 24
- 235000001014 amino acid Nutrition 0.000 abstract description 20
- XYUBQWNJDIAEES-UHFFFAOYSA-N 2-azaniumyl-3-phenylsulfanylpropanoate Chemical compound OC(=O)C(N)CSC1=CC=CC=C1 XYUBQWNJDIAEES-UHFFFAOYSA-N 0.000 abstract description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract description 2
- 239000004475 Arginine Substances 0.000 abstract description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract description 2
- 239000004471 Glycine Substances 0.000 abstract description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract description 2
- 235000004279 alanine Nutrition 0.000 abstract description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract description 2
- 235000018417 cysteine Nutrition 0.000 abstract description 2
- 229960003067 cystine Drugs 0.000 abstract description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract description 2
- 229960000310 isoleucine Drugs 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract description 2
- 239000004474 valine Substances 0.000 abstract description 2
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 117
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 52
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- AHYFYYVVAXRMKB-KRWDZBQOSA-N (2s)-3-(1h-indol-3-yl)-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)OCC1=CC=CC=C1 AHYFYYVVAXRMKB-KRWDZBQOSA-N 0.000 description 9
- RRONHWAVOYADJL-HNNXBMFYSA-N (2s)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 RRONHWAVOYADJL-HNNXBMFYSA-N 0.000 description 9
- FPKHNNQXKZMOJJ-NSHDSACASA-N (2s)-4-methylsulfanyl-2-(phenylmethoxycarbonylamino)butanoic acid Chemical compound CSCC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 FPKHNNQXKZMOJJ-NSHDSACASA-N 0.000 description 9
- 230000002378 acidificating effect Effects 0.000 description 9
- 230000032683 aging Effects 0.000 description 9
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 9
- ISBOGFMUFMJWEP-HNNXBMFYSA-N (2r)-2-(phenylmethoxycarbonylamino)-3-phenylsulfanylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)SC1=CC=CC=C1 ISBOGFMUFMJWEP-HNNXBMFYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 229960005190 phenylalanine Drugs 0.000 description 8
- 229960004452 methionine Drugs 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 229960004799 tryptophan Drugs 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- 229930195722 L-methionine Natural products 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- -1 alkali metal bicarbonates Chemical class 0.000 description 3
- 150000002168 ethanoic acid esters Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- 210000000692 cap cell Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 101710192523 30S ribosomal protein S9 Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、高純度N−保護基
−アミノ酸の製造法に関し、更に詳しくはN−保護基−
アミノ酸のアルカリ性溶液に水と混和しない有機溶媒を
加えて反応させる事で、副生不純物の生成を抑える事が
でき、該物質の高純度化を図れる方法に関する。すなわ
ち本発明は副生不純物含量の少ないN−保護基−アミノ
酸を効率よく、かつ高収率で製造する方法に関するもの
である。TECHNICAL FIELD The present invention relates to a method for producing a high-purity N-protecting group-amino acid, and more specifically to an N-protecting group-
The present invention relates to a method in which the production of by-product impurities can be suppressed by adding an organic solvent immiscible with water to an alkaline solution of an amino acid and the reaction can be performed, and the substance can be highly purified. That is, the present invention relates to a method for efficiently producing an N-protecting group-amino acid having a small amount of by-product impurities in a high yield.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】ベンジ
ルオキシカルボニル基は別名Z基とも呼ばれ、アミノ酸
及びアミノ酸誘導体の代表的なアミノ基保護基である。The benzyloxycarbonyl group, which is also known as Z group, is a typical amino group-protecting group for amino acids and amino acid derivatives.
【0003】アミノ酸及びアミノ酸誘導体へのZ基の導
入法としては、保護基試剤としてベンジルオキシカルボ
ニルクロライド(Z−Clと略す)を用い、Schot
ten−Baumann法で行われる場合が圧倒的に多
い。この方法は、アミノ酸を水酸化ナトリウム水溶液中
に溶解し、アルカリ性を保ちながらアミノ酸と等モル量
のZ−Clを滴下して行われる。(ペプチド合成、丸善
(株)発行、著者;泉屋信夫ら、p24〜28(197
5))。As a method for introducing a Z group into an amino acid and an amino acid derivative, benzyloxycarbonyl chloride (abbreviated as Z-Cl) is used as a protecting group reagent, and Schott is used.
In most cases, the ten-Baumann method is used. This method is carried out by dissolving an amino acid in an aqueous solution of sodium hydroxide and dropping Z-Cl in an equimolar amount to the amino acid while maintaining alkalinity. (Peptide Synthesis, published by Maruzen Co., Ltd., author; Nobuo Izumiya et al., P24-28 (197).
5)).
【0004】しかしながら、上述のような反応では副生
不純物が生成し、特に高濃度での反応では副生不純物の
生成が増大する。また、反応終了後にZ化物を酸性条件
下で有機溶媒に抽出する方法でも、多くの副生不純物は
有機溶媒に抽出され、分離は困難である。いずれの場合
でも、その後の副生不純物の除去、精製工程を必要とし
工業的製法としては好ましくない。よって反応工程で如
何に副生不純物の生成を抑えるかが課題であった。However, in the above-mentioned reaction, by-product impurities are produced, and particularly in the reaction at a high concentration, the production of by-product impurities is increased. Even by the method of extracting the Z-compound into an organic solvent under acidic conditions after completion of the reaction, many by-product impurities are extracted into the organic solvent and separation is difficult. In any case, subsequent removal of by-product impurities and purification steps are required, which is not preferable as an industrial production method. Therefore, how to suppress the production of by-product impurities in the reaction process has been a problem.
【0005】[0005]
【課題を解決するための手段】本発明者らは上記課題を
解決すべく鋭意検討した結果、アミノ酸にアルカリ性水
性媒体中で保護基を導入する反応において、水と混和し
ない有機溶媒を共存させる2層系での反応を行うことに
より副生不純物の生成を抑制することができることを見
いだし、本発明を完成するに至った。Means for Solving the Problems As a result of intensive studies to solve the above-mentioned problems, the present inventors have made an organic solvent immiscible with water coexist in the reaction of introducing a protecting group into an amino acid in an alkaline aqueous medium. It has been found that the production of by-product impurities can be suppressed by carrying out the reaction in a layer system, and the present invention has been completed.
【0006】すなわち、本発明はアミノ酸のアミノ基に
アルカリ水性媒体中で保護基を導入する反応において、
水と混和しない有機溶媒を共存させることを特徴とする
N−保護基−アミノ酸の製造法である。That is, the present invention provides a method for introducing a protecting group into an amino group of an amino acid in an alkaline aqueous medium,
A method for producing an N-protecting group-amino acid, which is characterized in that an organic solvent immiscible with water is allowed to coexist.
【0007】[0007]
【発明の実施の形態】本発明における高純度N−保護基
−アミノ酸の製造法の形態を以下に詳細に記す。BEST MODE FOR CARRYING OUT THE INVENTION The mode of the method for producing a high-purity N-protecting group-amino acid in the present invention is described in detail below.
【0008】まずアミノ酸をアルカリ水性媒体中に溶解
し、つづいて水と混和しない有機溶媒を加える。First, the amino acid is dissolved in an alkaline aqueous medium, and then an organic solvent immiscible with water is added.
【0009】本発明で原料として用いられるアミノ酸
は、天然物、非天然物を問わず、また、ラセミ体、光学
活性体およびそれらの誘導体等のいずれであってもよ
い。アミノ酸の例としてはアラニン、アルギニン、イソ
ロイシン、グリシン、グルタミン、シスチン、システイ
ン、セリン、チロシン、トリプトファン、バリン、フェ
ニルアラニン、S−フェニルシステイン、メチオニン、
ロイシン等が挙げられ、好ましくはS−フェニルシステ
イン、フェニルアラニン、トリプトファン又はメチオニ
ンであり、特に好ましくはS−フェニルシステインであ
る。The amino acid used as a raw material in the present invention may be a natural product or a non-natural product, and may be a racemic body, an optically active body or a derivative thereof. Examples of amino acids include alanine, arginine, isoleucine, glycine, glutamine, cystine, cysteine, serine, tyrosine, tryptophan, valine, phenylalanine, S-phenylcysteine, methionine,
Examples thereof include leucine and the like, preferably S-phenylcysteine, phenylalanine, tryptophan or methionine, and particularly preferably S-phenylcysteine.
【0010】本発明におけるアルカリ水性媒体中のアミ
ノ酸の濃度については、使用するアミノ酸が溶解する濃
度であれば全く問題はない。好ましくは4%〜50%濃
度である。Regarding the concentration of the amino acid in the alkaline aqueous medium in the present invention, there is no problem as long as the amino acid used is soluble. The concentration is preferably 4% to 50%.
【0011】本発明で用いられるアルカリとしては、一
般にアミノ基に保護基を導入する際に用いられるアルカ
リ金属水酸化物、アルカリ土類金属水酸化物、アルカリ
金属炭酸塩、アルカリ金属重炭酸塩等があり、具体的に
は水酸化ナトリウム、水酸化カリウム、炭酸水素ナトリ
ウム等が挙げられる。使用するアルカリの量は、反応に
充分な量であれば問題はない、好ましくはアミノ酸に対
して1倍〜5倍モル当量、特に好ましくは2.0倍〜
2.5倍モル当量である。As the alkali used in the present invention, there are generally used alkali metal hydroxides, alkaline earth metal hydroxides, alkali metal carbonates, alkali metal bicarbonates and the like which are used when introducing a protective group into an amino group. There are specifically, sodium hydroxide, potassium hydroxide, sodium hydrogencarbonate and the like. There is no problem as long as the amount of alkali used is a sufficient amount for the reaction, preferably 1 to 5 times the molar equivalent relative to the amino acid, particularly preferably 2.0 times to
It is 2.5 times the molar equivalent.
【0012】本発明で用いられる有機溶媒は水と混和し
ないものであれば良く、例えばベンゼン、トルエン、キ
シレン等の芳香族化合物等が上げられ、中でもトルエン
が好ましい。これらを2種類以上混合して用いても差し
支えない。水と混和しない溶媒の中でもクロロホルム、
ジクロロメタン等のハロゲン化物は、保護基を導入する
反応過程において原料と反応し多種多量の副生不純物を
生じる為に反応系への添加は好ましくない。また、同様
に酢酸エステル類等も同反応過程においてアルカリ下で
分解し、多種多量の副生不純物の生成を伴う為に、反応
系への添加は好ましくない。水と混和しない有機溶媒の
使用量は特に制限はないが、水層重量に対し50分の1
から3倍がよく、好ましくは、10分の1から等量の範
囲が好ましい。The organic solvent used in the present invention may be any one that is immiscible with water, and examples thereof include aromatic compounds such as benzene, toluene, xylene and the like, with toluene being particularly preferred. Two or more of these may be mixed and used. Among the water immiscible solvents, chloroform,
Halides such as dichloromethane react with the raw materials in the reaction process of introducing a protecting group to generate a large amount of by-product impurities, and therefore are not preferably added to the reaction system. Similarly, acetic acid esters and the like are decomposed under alkali in the same reaction process, and a large amount of by-product impurities are generated, so that addition to the reaction system is not preferable. The amount of the organic solvent immiscible with water is not particularly limited, but it is 1/50 of the weight of the water layer.
To 3 times, preferably from 1/10 to an equivalent amount.
【0013】以上のようにして、調製された有機溶媒の
共存するアミノ酸アルカリ水性媒体の二層液中にアミノ
基の保護基となる試剤(例えばZ−Cl)を滴下添加
し、アミノ基への保護基の導入を行う。As described above, a reagent (for example, Z-Cl) which serves as a protective group for an amino group is added dropwise to a two-layer liquid of an amino acid alkaline aqueous medium in which an organic solvent coexists, and the amino group is added to the amino group. Introduce a protecting group.
【0014】本発明で用いられるアミノ基の保護基とし
ては、たとえば核置換もしくは無置換のベンジルオキシ
カルボニル基などがあげられ、保護基となる試剤として
は例えばZ−Clが挙げられる。保護基となる試剤の使
用量は反応に充分な量であれば問題はない、好ましくは
アミノ酸に対して0.9〜1.1倍モル当量である。反
応温度は50℃以下、好ましくは10℃〜25℃で行う
ことが望ましい。The amino-protecting group used in the present invention may be, for example, a nucleus-substituted or unsubstituted benzyloxycarbonyl group, and the protecting-group reagent may be Z-Cl. There is no problem as long as the amount of the reagent used as a protective group is sufficient for the reaction, and it is preferably 0.9 to 1.1 times the molar equivalent relative to the amino acid. The reaction temperature is 50 ° C. or lower, preferably 10 ° C. to 25 ° C.
【0015】本発明により生成したN−保護基−アミノ
酸の単離・精製は公知の方法に従い、行う事が出来る。
例えば、アルカリ下で有機溶媒を分液除去した水層に塩
酸を加えて晶析し単離するか、反応後に塩酸を加えてN
保護基アミノ酸を有機溶媒層に抽出して分液後、有機溶
媒層に貧溶媒を加え晶析、或いは冷却晶析等いずれの手
法で単離しても良い。生成したN−保護基−アミノ酸が
反応に使用した有機溶媒に不溶の場合は、その有機溶媒
を分液除去後、新たに水層にN−保護基−アミノ酸が可
溶の有機溶媒を加え、塩酸を加えてN保護基アミノ酸を
有機溶媒に抽出、分液後、有機溶媒層に貧溶媒を加え晶
析、或いは冷却晶析等の手法で単離すれば良い。この場
合、新たに加える有機溶媒には特に指定はなく、ベンゼ
ン、トルエン、キシレン等の芳香族化合物、クロロホル
ム、ジクロロメタン等のハロゲン化物、酢酸メチル、酢
酸エチル、酢酸ブチル等の酢酸エステル類、ブタノー
ル、ベンジルアルコール等のアルコール類等、水と混和
しないものであればなんでも良い。中でも好ましくは酢
酸メチル、酢酸エチル、酢酸ブチル等の酢酸エステル類
である。The N-protecting group-amino acid produced according to the present invention can be isolated and purified by a known method.
For example, hydrochloric acid is added to the aqueous layer from which the organic solvent has been separated and removed under alkali to crystallize and isolate it, or after the reaction, add hydrochloric acid to add N.
The protecting group amino acid may be extracted into the organic solvent layer, and after liquid separation, a poor solvent may be added to the organic solvent layer for crystallization or cooling crystallization. When the produced N-protecting group-amino acid is insoluble in the organic solvent used for the reaction, after removing the organic solvent by liquid separation, an organic solvent in which the N-protecting group-amino acid is soluble is newly added to the aqueous layer, Hydrochloric acid may be added to extract the N-protecting group amino acid in an organic solvent, and after liquid separation, a poor solvent may be added to the organic solvent layer for crystallization or may be isolated by cooling crystallization. In this case, the organic solvent to be newly added is not particularly specified, aromatic compounds such as benzene, toluene, xylene, chloroform, halides such as dichloromethane, methyl acetate, ethyl acetate, acetic acid esters such as butyl acetate, butanol, Any alcohol, such as benzyl alcohol, that is immiscible with water may be used. Of these, acetic acid esters such as methyl acetate, ethyl acetate and butyl acetate are preferable.
【0016】[0016]
【実施例】以下、実施例により本発明の方法を詳しく説
明する。
実施例1
S−フェニル−L−システイン100.0g(0.50
7mol)を227.2gの水に懸濁し、45%水酸化
ナトリウム溶液92.4g(1.039mol)を加え
溶解した。これに339gのトルエンを加えた後、10
℃、撹拌下でZ−Cl 86.4g(0.507mo
l)をゆっくり滴下した。滴下終了後は約1時間ほど熟
成した。熟成後、昇温し内温が40℃になったら、35
%塩酸105.7g(1.014mol)を加え、水層
のpHを酸性とした。引き続き昇温し内温60℃で、N
−カルボベンゾキシ−S−フェニル−L−システインを
トルエン層に抽出した。抽出操作後、分液操作によりN
−カルボベンゾキシ−S−フェニル−L−システインの
トルエン溶液513.1gを得た。濃度分析によりN−
カルボベンゾキシ−S−フェニル−L−システインは3
2.2%濃度で、165g(0.498mol)を得
た。反応成績は対S−フェニル−L−システイン収率で
98.3%であった。該N−カルボベンゾキシ−S−フ
ェニル−L−システインのトルエン溶液につきHPLC
分析を行った。N−カルボベンゾキシ−S−フェニル−
L−システインは95.7%、その他副生不純物は4.
3%であった(トルエンは除外)。水層系反応(比較例
1)に比べて副生不純物の生成量が少なく高純度である
事を確認した。比較結果を表1に示す。EXAMPLES The method of the present invention will be described in detail below with reference to examples. Example 1 100.0 g (0.50) of S-phenyl-L-cysteine
7 mol) was suspended in 227.2 g of water, and 92.4 g (1.039 mol) of 45% sodium hydroxide solution was added and dissolved. After adding 339 g of toluene to this, 10
86.4 g (0.507 mo) of Z-Cl under stirring at ℃.
1) was slowly added dropwise. After completion of dropping, the mixture was aged for about 1 hour. After aging, the temperature was raised and the internal temperature reached 40 ° C.
% Hydrochloric acid 105.7 g (1.014 mol) was added to make the pH of the aqueous layer acidic. Then, the temperature is raised and the internal temperature is 60 ° C.
-Carbobenzoxy-S-phenyl-L-cysteine was extracted into the toluene layer. After extraction operation, N
513.1 g of a toluene solution of -carbobenzoxy-S-phenyl-L-cysteine was obtained. N- by concentration analysis
Carbobenzoxy-S-phenyl-L-cysteine is 3
At a 2.2% concentration, 165 g (0.498 mol) was obtained. The reaction result was 98.3% in terms of yield relative to S-phenyl-L-cysteine. HPLC of the toluene solution of N-carbobenzoxy-S-phenyl-L-cysteine
Analysis was carried out. N-carbobenzoxy-S-phenyl-
L-cysteine is 95.7% and other by-product impurities are 4.
3% (toluene excluded). It was confirmed that the amount of by-product impurities was smaller than that in the aqueous layer reaction (Comparative Example 1) and the purity was high. The comparison results are shown in Table 1.
【0017】実施例2
L−フェニルアラニン 100.0g(0.605mo
l)を292.4gの水に懸濁し、45%水酸化ナトリ
ウム溶液107.6g(1.211mol)を加え溶解
した。これに292gのトルエンを加えた後、10℃、
撹拌下でZ−Cl 103.2g(0.605mol)
をゆっくり滴下した。滴下終了後は約1時間ほど熟成し
た。熟成後、昇温し内温が40℃になったら、35%塩
酸126.2g(1.210mol)を加え、水層のp
Hを酸性とした。引き続き昇温し内温60℃で、N−カ
ルボベンゾキシ−L−フェニルアラニンをトルエン層に
抽出した。抽出操作後、分液操作によりN−カルボベン
ゾキシ−L−フェニルアラニンのトルエン溶液467g
を得た。濃度分析によりN−カルボベンゾキシ−L−フ
ェニルアラニンは35.9%濃度で、167.4g
(0.559mol)を得た。反応成績は対L−フェニ
ルアラニン収率で92.4%であった。該N−カルボベ
ンゾキシ−L−フェニルアラニンのトルエン溶液につき
HPLC分析を行った所、N−カルボベンゾキシ−L−
フェニルアラニンは96.1%、その他副生不純物は
3.9%であった(トルエンは除外)。水層系反応(比
較例2)に比べて副生不純物の生成量が少なく高純度で
ある事を確認した。比較結果を表2に示す。Example 2 L-phenylalanine 100.0 g (0.605 mo)
l) was suspended in 292.4 g of water, and 107.6 g (1.211 mol) of 45% sodium hydroxide solution was added and dissolved. After adding 292 g of toluene to this, 10 ° C,
103.2 g (0.605 mol) of Z-Cl under stirring
Was slowly added dropwise. After completion of dropping, the mixture was aged for about 1 hour. After aging, the temperature was raised and when the internal temperature reached 40 ° C., 126.2 g (1.210 mol) of 35% hydrochloric acid was added, and the p
H was made acidic. Subsequently, the temperature was raised and the internal temperature was 60 ° C., and N-carbobenzoxy-L-phenylalanine was extracted into the toluene layer. After the extraction operation, N-carbobenzoxy-L-phenylalanine toluene solution 467 g by liquid separation operation
Got According to the concentration analysis, N-carbobenzoxy-L-phenylalanine was 37.4% and had a concentration of 167.4 g.
(0.559 mol) was obtained. The reaction result was 92.4% based on the yield of L-phenylalanine. When the toluene solution of the N-carbobenzoxy-L-phenylalanine was analyzed by HPLC, N-carbobenzoxy-L-
Phenylalanine was 96.1% and other by-product impurities were 3.9% (toluene was excluded). It was confirmed that the amount of by-product impurities produced was smaller and the purity was higher than in the aqueous layer reaction (Comparative Example 2). The comparison results are shown in Table 2.
【0018】実施例3
L−トリプトファン 100.0g(0.490mo
l)を312.9gの水に懸濁し、45%水酸化ナトリ
ウム溶液87.1g(0.980 mol)を加え溶解
した。これに292gのトルエンを加えた後、10℃、
撹拌下でZ−Cl 87.9g(0.515mol)を
ゆっくり滴下した。滴下終了後は約1時間ほど熟成し
た。熟成後、トルエンを分液除去し、水層に酢酸エチル
292gと35%塩酸102.2g(0.980mo
l)を加え、水層のpHを酸性とし、N−カルボベンゾ
キシ−L−トリプトファンを酢酸エチル層に抽出した。
抽出操作後、分液操作によりN−カルボベンゾキシ−L
−トリプトファンの酢酸エチル溶液450.4gを得
た。濃度分析によりN−カルボベンゾキシ−L−トリプ
トファンは34.1%濃度で、153.4g(0.45
3mol)を得た。反応成績は対L−トリプトファン収
率で92.5%であった。該N−カルボベンゾキシ−L
−トリプトファンの酢酸エチル溶液につきHPLC分析
を行った所、N−カルボベンゾキシ−L−トリプトファ
ンは97.9%、その他副生不純物は2.1%であった
(トルエンは除外)。水層系反応(比較例3)に比べて
副生不純物の生成量が少なく高純度である事を確認し
た。比較結果を表3に示す。Example 3 L-tryptophan 100.0 g (0.490 mo)
l) was suspended in 312.9 g of water, and 87.1 g (0.980 mol) of 45% sodium hydroxide solution was added and dissolved. After adding 292 g of toluene to this, 10 ° C,
With stirring, Z-Cl (87.9 g, 0.515 mol) was slowly added dropwise. After completion of dropping, the mixture was aged for about 1 hour. After aging, the toluene was separated and removed, and the aqueous layer was treated with 292 g of ethyl acetate and 102.2 g of 35% hydrochloric acid (0.980 mo).
1) was added to make the pH of the aqueous layer acidic, and N-carbobenzoxy-L-tryptophan was extracted into the ethyl acetate layer.
After the extraction operation, N-carbobenzoxy-L was separated by liquid separation operation.
450.4 g of a solution of tryptophan in ethyl acetate was obtained. According to the concentration analysis, N-carbobenzoxy-L-tryptophan was found to be 153.4 g (0.45%) at a concentration of 34.1%.
3 mol) was obtained. The reaction result was 92.5% with respect to the yield of L-tryptophan. The N-carbobenzoxy-L
HPLC analysis of a tryptophan-ethyl acetate solution revealed that N-carbobenzoxy-L-tryptophan was 97.9% and other by-product impurities were 2.1% (toluene was excluded). It was confirmed that the amount of by-product impurities produced was smaller and the purity was higher than in the aqueous layer reaction (Comparative Example 3). The comparison results are shown in Table 3.
【0019】実施例4
L−メチオニン 100.0g(0.670mol)を
280.9gの水に懸濁し、45%水酸化ナトリウム溶
液119.1g(1.34mol)を加え溶解した。こ
れに292gのトルエンを加えた後、10℃、撹拌下で
Z−Cl 120.0g(0.704mol)をゆっく
り滴下した。滴下終了後は約1時間ほど熟成した。熟成
後、トルエンを分液除去し、水層に酢酸エチル292g
と35%塩酸139.7g(1.34mol)を加え、
水層のpHを酸性とし、N−カルボベンゾキシ−L−メ
チオニンを酢酸エチル層に抽出した。抽出操作後、分液
操作によりN−カルボベンゾキシ−L−メチオニンの酢
酸エチル溶液483.3gを得た。濃度分析によりN−
カルボベンゾキシ−L−メチオニンは38.7%濃度
で、187.0g(0.660mol)を得た。反応成
績は対L−メチオニン収率で98.5%であった。該N
−カルボベンゾキシ−L−メチオニンの酢酸エチル溶液
につきHPLC分析を行った所、N−カルボベンゾキシ
−L−メチオニンは93.0%、その他副生不純物は
7.0%であった(トルエンは除外)。水層系反応(比
較例4)に比べて副生不純物の生成量が少なく高純度で
ある事を確認した。比較結果を表4に示す。Example 4 100.0 g (0.670 mol) of L-methionine was suspended in 280.9 g of water, and 119.1 g (1.34 mol) of 45% sodium hydroxide solution was added and dissolved. After adding 292 g of toluene thereto, 120.0 g (0.704 mol) of Z-Cl was slowly added dropwise at 10 ° C. under stirring. After completion of dropping, the mixture was aged for about 1 hour. After aging, the toluene was separated and removed, and the aqueous layer was 292 g of ethyl acetate.
And 359.7% hydrochloric acid 139.7 g (1.34 mol) were added,
The pH of the aqueous layer was made acidic and N-carbobenzoxy-L-methionine was extracted into the ethyl acetate layer. After the extraction operation, a liquid separation operation was performed to obtain 483.3 g of an ethyl acetate solution of N-carbobenzoxy-L-methionine. N- by concentration analysis
Carbobenzoxy-L-methionine was obtained at a concentration of 38.7% to obtain 187.0 g (0.660 mol). The reaction result was 98.5% based on the yield of L-methionine. The N
HPLC analysis of a solution of -carbobenzoxy-L-methionine in ethyl acetate revealed that N-carbobenzoxy-L-methionine was 93.0% and other by-product impurities were 7.0% (toluene: Excluded). It was confirmed that the amount of by-product impurities produced was smaller and the purity was higher than in the aqueous layer reaction (Comparative Example 4). The comparison results are shown in Table 4.
【0020】比較例1
実施例1の反応をトルエンを加えずに行い滴下終了後は
1時間熟成した。熟成後トルエン339gを加え、昇温
し内温が40℃になったら、35%塩酸105.7g
(1.014mol)を加え、水層のpHを酸性とし
た。引き続き昇温し内温60℃で、N−カルボベンゾキ
シ−S−フェニル−L−システインをトルエン層に抽出
した。抽出操作後、分液操作によりN−カルボベンゾキ
シ−S−フェニル−L−システインをトルエン溶液47
6.7gを得た。濃度分析によりN−カルボベンゾキシ
−S−フェニル−L−システインは28.5%濃度で、
136.1g(0.411mol)を得た。反応成績は
対L−フェニルアラニン収率で81.0%であった。該
N−カルボベンゾキシ−S−フェニル−L−システイン
のトルエン溶液につきHPLC分析を行った所、N−カ
ルボベンゾキシ−S−フェニル−L−システインは7
4.2%、その他副生不純物は25.8%であった(ト
ルエンは除外)。Comparative Example 1 The reaction of Example 1 was carried out without adding toluene, and after completion of dropping, aging was carried out for 1 hour. After aging, 339 g of toluene was added, the temperature was raised, and when the internal temperature reached 40 ° C, 105.7 g of 35% hydrochloric acid was added.
(1.014 mol) was added to make the pH of the aqueous layer acidic. Subsequently, the temperature was raised and the internal temperature was 60 ° C., and N-carbobenzoxy-S-phenyl-L-cysteine was extracted into the toluene layer. After the extraction operation, N-carbobenzoxy-S-phenyl-L-cysteine was added to a toluene solution 47 by a liquid separation operation.
6.7 g was obtained. According to the concentration analysis, N-carbobenzoxy-S-phenyl-L-cysteine was 28.5% concentration,
136.1 g (0.411 mol) was obtained. The reaction result was 81.0% in terms of yield relative to L-phenylalanine. HPLC analysis of the toluene solution of N-carbobenzoxy-S-phenyl-L-cysteine revealed that N-carbobenzoxy-S-phenyl-L-cysteine was 7%.
4.2% and other by-product impurities were 25.8% (excluding toluene).
【0021】比較例2
実施例2の反応をトルエンを加えずに行った。滴下終了
後は1時間熟成した。熟成後トルエン292gを加え、
昇温し内温が40℃になったら、35%塩酸126.2
g(1.210mol)を加え、水層のpHを酸性とし
た。引き続き昇温し内温60℃で、N−カルボベンゾキ
シ−L−フェニルアラニンをトルエン層に抽出した。抽
出操作後、分液操作によりN−カルボベンゾキシ−L−
フェニルアラニンのトルエン溶液465.8gを得た。
濃度分析によりN−カルボベンゾキシ−L−フェニルア
ラニンは35.6%濃度で、165.9g(0.554
mol)を得た。反応成績は対L−フェニルアラニン収
率で91.6%であった。該N−カルボベンゾキシ−L
−フェニルアラニンのトルエン溶液につきHPLC分析
を行った所、N−カルボベンゾキシ−L−フェニルアラ
ニンは87.2%、その他副生不純物は12.8%であ
った(トルエンは除外)。Comparative Example 2 The reaction of Example 2 was carried out without adding toluene. After completion of dropping, the mixture was aged for 1 hour. After aging, add 292 g of toluene,
When the temperature rises and the internal temperature reaches 40 ° C, 35% hydrochloric acid 126.2
g (1.210 mol) was added to make the pH of the aqueous layer acidic. Subsequently, the temperature was raised and the internal temperature was 60 ° C., and N-carbobenzoxy-L-phenylalanine was extracted into the toluene layer. After the extraction operation, N-carbobenzoxy-L-
465.8 g of a toluene solution of phenylalanine was obtained.
According to the concentration analysis, N-carbobenzoxy-L-phenylalanine had a concentration of 35.6% and contained 165.9 g (0.554%).
mol) was obtained. The reaction result was 91.6% in terms of yield relative to L-phenylalanine. The N-carbobenzoxy-L
HPLC analysis of a toluene solution of -phenylalanine revealed that N-carbobenzoxy-L-phenylalanine was 87.2% and other by-product impurities were 12.8% (toluene was excluded).
【0022】比較例3
実施例3の反応をトルエンを加えずに行った。滴下終了
後は1時間熟成した。熟成後、実施例3と条件をそろえ
るため、トルエン292gを加え、洗浄の後トルエン層
を分液除去した。その後水層に酢酸エチル292gと3
5%塩酸102.2g(0.980mol)を加え、水
層のpHを酸性とし、N−カルボベンゾキシ−L−トリ
プトファンを酢酸エチル層に抽出した。抽出操作後、分
液操作によりN−カルボベンゾキシ−L−トリプトファ
ンの酢酸エチル溶液448.0gを得た。濃度分析によ
りN−カルボベンゾキシ−L−トリプトファンは33.
7%濃度で、151.0g(0.446mol)を得
た。反応成績は対L−トリプトファン収率で91.1%
であった。該N−カルボベンゾキシ−L−トリプトファ
ンの酢酸エチル溶液につきHPLC分析を行った所、N
−カルボベンゾキシ−L−トリプトファンは93.0
%、その他副生不純物は7.0%であった(トルエンは
除外)。Comparative Example 3 The reaction of Example 3 was carried out without the addition of toluene. After completion of dropping, the mixture was aged for 1 hour. After the aging, in order to meet the same conditions as in Example 3, 292 g of toluene was added, and after washing, the toluene layer was separated and removed. After that, 292 g of ethyl acetate and 3 were added to the water layer.
102.2 g (0.980 mol) of 5% hydrochloric acid was added to make the pH of the aqueous layer acidic, and N-carbobenzoxy-L-tryptophan was extracted into the ethyl acetate layer. After the extraction operation, a liquid separation operation was performed to obtain 448.0 g of an ethyl acetate solution of N-carbobenzoxy-L-tryptophan. Concentration analysis revealed that N-carbobenzoxy-L-tryptophan was 33.
151.0 g (0.446 mol) was obtained at a 7% concentration. The reaction result was 91.1% in terms of yield relative to L-tryptophan.
Met. HPLC analysis of the ethyl acetate solution of N-carbobenzoxy-L-tryptophan revealed that N
-Carbobenzoxy-L-tryptophan is 93.0
%, And other by-product impurities were 7.0% (toluene was excluded).
【0023】比較例4
実施例4の反応をトルエンを加えずに行った。滴下終了
後は1時間熟成した。熟成後、実施例4と条件をそろえ
るため、トルエン292gを加え、洗浄の後トルエン層
を分液除去した。その後水層に酢酸エチル292gと3
5%塩酸139.7g(1.34mol)を加え、水層
のpHを酸性とし、N−カルボベンゾキシ−L−メチオ
ニンを酢酸エチル層に抽出した。抽出操作後、分液操作
によりN−カルボベンゾキシ−L−メチオニンの酢酸エ
チル溶液478.8gを得た。濃度分析によりN−カル
ボベンゾキシ−L−メチオニンは38.2%濃度で、1
83.0g(0.645mol)を得た。反応成績は対
L−メチオニン収率で96.4%であった。該N−カル
ボベンゾキシ−L−メチオニンの酢酸エチル溶液につき
HPLC分析を行った所、N−カルボベンゾキシ−L−
メチオニンは89.4%、その他副生不純物は10.6
%であった(トルエンは除外)。Comparative Example 4 The reaction of Example 4 was carried out without the addition of toluene. After completion of dropping, the mixture was aged for 1 hour. After the aging, in order to meet the same conditions as in Example 4, 292 g of toluene was added, and after washing, the toluene layer was separated and removed. After that, 292 g of ethyl acetate and 3 were added to the water layer.
139.7 g (1.34 mol) of 5% hydrochloric acid was added to make the pH of the aqueous layer acidic, and N-carbobenzoxy-L-methionine was extracted into the ethyl acetate layer. After the extraction operation, a liquid separation operation was performed to obtain 478.8 g of an ethyl acetate solution of N-carbobenzoxy-L-methionine. Concentration analysis revealed that N-carbobenzoxy-L-methionine had a concentration of 38.2% and 1
83.0 g (0.645 mol) was obtained. The reaction result was 96.4% in terms of yield relative to L-methionine. When HPLC analysis was performed on the ethyl acetate solution of N-carbobenzoxy-L-methionine, N-carbobenzoxy-L-
Methionine 89.4%, other by-product impurities 10.6
% (Toluene excluded).
【0024】[0024]
【表1】 [Table 1]
【表2】 [Table 2]
【表3】 [Table 3]
【表4】 [Table 4]
【0025】N−カルボベンゾキシ−アミノ酸の不純物
分析はODSカラム CAPCELL PAK C18
(SHISEIDO社製)を用いたHPLC分析によ
り行った。分析条件を以下に示す。
〔分析HPLC条件〕
カラム;CAPCELL PAK C18 (SHIS
EIDO社製)
φ6.0mm × 250mm
移動相;10mM りん酸/アセトニトリル=53/
47
温度 ;40℃
流量 ;1.5ml/min
検出 ;UV(210nm)
保持時間;N−カルボベンゾキシ−S−フェニル−L−
システイン=6.2分
N−カルボベンゾキシ−L−フェニルアラニン=4.9
分
N−カルボベンゾキシ−L−トリプトファン=4.3分
N−カルボベンゾキシ−L−メチオニン=3.5分Impurity analysis of N-carbobenzoxy-amino acid was carried out by ODS column CAPCELL PAK C18.
(Manufactured by SHISEIDO) was used for HPLC analysis. The analysis conditions are shown below. [Analytical HPLC conditions] Column: CAPCELL PAK C18 (SHIS
Φ6.0 mm × 250 mm mobile phase; 10 mM phosphoric acid / acetonitrile = 53 /
47 temperature; 40 ° C. flow rate; 1.5 ml / min detection; UV (210 nm) retention time; N-carbobenzoxy-S-phenyl-L-
Cysteine = 6.2 min N-carbobenzoxy-L-phenylalanine = 4.9
Min N-carbobenzoxy-L-tryptophan = 4.3 min N-carbobenzoxy-L-methionine = 3.5 min
【0026】[0026]
【発明の効果】本発明によれば、特に高濃度反応系にお
いて、反応工程での副生不純物の生成を抑える事を可能
にした事により、高純度のN保護基アミノ酸を高収率か
つ効率よく製造することが可能となった。INDUSTRIAL APPLICABILITY According to the present invention, particularly in a high-concentration reaction system, it is possible to suppress the production of by-product impurities in the reaction step, and thus a high-purity N-protecting group amino acid can be obtained in high yield and efficiency. It has become possible to manufacture well.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 吉野 節生 福岡県大牟田市浅牟田町30番地 三井化学 株式会社内 (72)発明者 福原 信裕 福岡県大牟田市浅牟田町30番地 三井化学 株式会社内 Fターム(参考) 4H006 AA02 AC80 BB11 BB31 BC35 BJ50 BS10 NB22 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Seto Yoshino 30 Asamu-cho, Omuta-shi, Fukuoka Mitsui Chemicals Within the corporation (72) Inventor Nobuhiro Fukuhara 30 Asamu-cho, Omuta-shi, Fukuoka Mitsui Chemicals Within the corporation F-term (reference) 4H006 AA02 AC80 BB11 BB31 BC35 BJ50 BS10 NB22
Claims (5)
で保護基を導入する反応において、水と混和しない有機
溶媒を共存させることを特徴とするN−保護基−アミノ
酸の製造法。1. A process for producing an N-protecting group-amino acid, which comprises allowing an organic solvent immiscible with water to coexist in a reaction of introducing a protecting group into an amino group of an amino acid in an alkaline aqueous medium.
ン、フェニルアラニン、トリプトファン、メチオニンの
群から選ばれるものである請求項1記載の製造法。2. The method according to claim 1, wherein the amino acid is selected from the group consisting of S-phenyl-L-cysteine, phenylalanine, tryptophan and methionine.
のベンジルオキシカルボニル基である請求項1記載の製
造法。3. The method according to claim 1, wherein the amino-protecting group is a nucleus-substituted or unsubstituted benzyloxycarbonyl group.
類である請求項1記載の製造法。4. The method according to claim 1, wherein the water-immiscible organic solvent is an aromatic hydrocarbon.
ら50%の範囲である請求項1記載の製造法。5. The method according to claim 1, wherein the charged concentration of amino acid is in the range of 4% to 50% with respect to water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10229609A JP2000063339A (en) | 1998-08-14 | 1998-08-14 | Production of n-protective group-amino acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10229609A JP2000063339A (en) | 1998-08-14 | 1998-08-14 | Production of n-protective group-amino acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000063339A true JP2000063339A (en) | 2000-02-29 |
Family
ID=16894866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10229609A Withdrawn JP2000063339A (en) | 1998-08-14 | 1998-08-14 | Production of n-protective group-amino acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000063339A (en) |
-
1998
- 1998-08-14 JP JP10229609A patent/JP2000063339A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102303092B1 (en) | Method for producing synthetic pentapeptide | |
| JP2004161749A (en) | Method for producing optically active, nitrogen-containing compound | |
| US9663450B2 (en) | Process for the purification of melphalan | |
| JPWO1999033785A1 (en) | Methods for producing β-halogeno-α-aminocarboxylic acids, phenylcysteine derivatives, and intermediates thereof | |
| JPH052317B2 (en) | ||
| US6949658B2 (en) | Process for producing optically active α-amino acid and optically active α-amino acid amide | |
| JP2000063339A (en) | Production of n-protective group-amino acid | |
| CN112876502B (en) | Preparation method of N-trimethylsiloxyethoxycarbonyl-N-methyl-L/D-leucine | |
| JP2862167B2 (en) | Method for recovering optically active amino acid derivative | |
| JP4035856B2 (en) | Method for producing high optical purity optically active amino acid ester | |
| JP5122871B2 (en) | Process for producing optically active N-benzyloxycarbonylamino acid and diastereomeric salt | |
| JP2008260755A (en) | Method for recovering salt of L-biphenylalanine compound and method for recovering biphenylalanine ester compound using the same | |
| JP3888402B2 (en) | Process for producing optically active N-carbobenzoxy-tert-leucine | |
| US6316657B1 (en) | Process for purification or recovery of sweetener | |
| JP2000063350A (en) | Method for purifying optically active n-protecting group- having amino acid ester | |
| EP2502896B1 (en) | A process for the preparation of enantiomerically pure tert-leucine | |
| Overby et al. | Resolution of N-Carbobenzoxy Amino Acids. Alanine, Phenylalanine and Tryptophan | |
| EP0262010A1 (en) | Process for the stereo-specific esterification of an amino acid mixture by reaction of the mixture in the esterification alcohol in the presence of papain | |
| EP0474096B2 (en) | Method for extracting amino acid ester | |
| FR2753966A1 (en) | Optically pure aminoacid preparation | |
| EP0209430B1 (en) | L-di or tripeptides possessing a biological activity for use in human and veterinary medicines, process for their obtention and medicines containing them | |
| JP4730913B2 (en) | Optically active tert-leucine and method for producing optically active tert-leucine amide | |
| JPH11100364A (en) | Production of high-purity n-protected s-phenylcysteine | |
| JP2001031635A (en) | Production of optically active n-protected-n-methyl- phenylalanine derivative | |
| JP2002179645A (en) | Method for producing n-protected amino acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20061109 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20061109 |